Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.

Slides:



Advertisements
Similar presentations
Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
Advertisements

National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Translational Cancer Research From Laboratory to Practice William J Catalona MD Professor of Urology Director, Clinical Prostate Cancer Program Northwestern.
Professor of Hematology, Oncology, Medicine and Epidemiology
An Introduction to Cancer Biology Geoff Mitchell April 24, 2007.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
1 Cancer PREVENTION “Take charge of your life and learn as much as you can about illness. Knowledge generates hope.” Lance Armstrong Winner of 6 Tour de.
Men’s Health & Prostate Cancer Appathurai Balamurugan MD, MPH Section Chief, Chronic Disease Epidemiology, Epidemiology Branch, CPHP, Arkansas Department.
Cancer and Minorities Norma Kanarek, MPH, PhD Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health Department of.
Cancer: The Clinical and Diagnostic Approach
03/20151 Back to Basics, 2015 POPULATION HEALTH : Vital & Health Statistics Dr. Nicholas Birkett School of Epidemiology, Public Health and Preventive Medicine.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Health Report on Cancer Bryan Gregory (Extra Credit Presentation)
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
BIOE 301 Lecture Twelve Jair Martinez Bioengineering Department Rice University.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.
RankCause of DeathNumberDeath Rate % of Deaths All causes2,543, % 1Diseases of the heart 599, Malignant neoplasms 582,
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Causes and Treatment.
Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.
THE CELL CYCLE AND CANCER. Control of the Cell cycle Control of the cell cycle.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
BME 301 Lecture Twelve.
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Fall, 2005.
Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Summer, 2006.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
Bioengineering and World Health Lecture Twelve. Four Questions What are the major health problems worldwide? Who pays to solve problems in health care?
Homework #3 is due 11/19 Bonus #2 is posted. Cancer: is the loss of control over cell division. Tumors are normal cells that are dividing inappropriately.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
03/20121 Back to Basics, 2012 POPULATION HEALTH : Vital & Health Statistics Presented by N. Birkett, MD Epidemiology & Community Medicine.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
The Cancer Burden in Iowa: Data Overview. Treatment BirthDeathCancer Diagnosis Genes Environment Etiology & Prevention Early Detection Quantity & Quality.
Improving Community Health through Planning and Partnerships Albemarle and Charlottesville Community Health Council.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Cell Division Mitosis. Why do they have to be so small? Why not keep growing – why divide? Surface area to Volume ratio Too much volume, too little space.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Quality of Life after Prostate Cancer Treatment: Trajectories of Recovery using Piecewise Latent Growth Curve Analyses Michael A. Diefenbach, Ph.D., Icahn.
Age-adjusted death rates by type of cancer by race, Kansas City, Missouri, Death rateDisparity ratio Causes of cancer 2020 objectiveAllWhiteBlackWhiteBlack.
2007 Pitt County Community Health Assessment Review of Secondary Data September 13, 2007.
What is cancer?. Cancer Development of abnormal cells Divide uncontrollably Can infiltrate and destroy normal body tissue.
The Changing Face of Cancer in Iowa
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Cancer in Ontario 1 An Overview
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
5 Prevalence ZEINAB This module presents statistics from Chapter 5: Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Non-Communicable Diseases Lesson 7
Racial Disparity in Smoking-Attributable Mortality, Years of Potential Life Lost: Case of Missouri Noaman Kayani, PhD Chronic Disease and Nutrition.
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Estimated current cancer incidence
The Changing Face of Cancer in Iowa
Presentation transcript:

Epidemiology of Oral Cancer Module 1:

Epidemiology of Cancer, U.S.

US Mortality, 2001 Source: US Mortality Public Use Data Tape 2001, National Center for Health Statistics, Centers for Disease Control and Prevention, Heart Diseases700, Cancer553, Cerebrovascular diseases163, Chronic lower respiratory diseases123, Accidents (Unintentional injuries)101, Diabetes mellitus 71, Influenza and Pneumonia 62, Alzheimer’s disease 53, Nephritis 39, Septicemia 32, RankCause of Death No. of deaths % of all deaths

2004 Estimated US Cancer Cases* *Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder. American Cancer Society, Men 699,560 Women 668,470 32%Breast 12%Lung & bronchus 11%Colon & rectum 6%Uterine corpus 4%Ovary 4%Non-Hodgkin lymphoma 4%Melanoma of skin 3%Thyroid 2%Pancreas 2%Urinary bladder 20%All Other Sites Prostate33% Lung & bronchus13% Colon & rectum11% Urinary bladder6% Melanoma of skin4% Non-Hodgkin lymphoma4% Kidney3% Oral Cavity3% Leukemia3% Pancreas2% All Other Sites18%

Lifetime Probability of Developing Cancer, by Site, Men, US, Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 5.1 Statistical Research and Applications Branch, NCI, SiteRisk All sites 1 in 2 Prostate 1 in 6 Lung & bronchus1 in 13 Colon & rectum1 in 17 Urinary bladder1 in 29 Non-Hodgkin lymphoma1 in 48 Melanoma1 in 55 Kidney1 in 69 Leukemia1 in 70 Oral cavity1 in 72

Lifetime Probability of Developing Cancer, by Site, Women, US, Source:DevCan: Probability of Developing or Dying of Cancer Software, Version 5.1 Statistical Research and Applications Branch, NCI, SiteRisk All sites 1 in 3 Breast 1 in 7 Lung & bronchus 1 in 17 Colon & rectum 1 in 18 Uterine corpus 1 in 38 Non-Hodgkin lymphoma 1 in 57 Ovary 1 in 59 Pancreas 1 in 83 Melanoma 1 in 82 Urinary bladder 1 in 91 Uterine cervix1 in 128

Estimated New Oral Cancer Cases & Deaths by Sex, US, 2004* Estimated New Cases Estimated Deaths Both Sexes Male Female Both Sexes Males Females All sites 1,368, , , , , ,810 Oral cavity/pharynx 28,260 18,550 9,710 7,230 4,830 2,400 Tongue 7,320 4,860 2,460 1,700 1, Mouth 10,080 5,410 4,670 1,890 1, Pharynx 8,250 6,330 1,920 2,070 1, Other oral cavity 2,610 1, ,570 1,

What is oral cancer?  Cancer that starts in the mouth is oral cavity cancer –Includes lips –Inside lining of cheeks (buccal mucosa) –Gingiva (gums) –Floor of the mouth –Anterior 2/3rds of the tongue –Hard palate

Oropharyngeal cancer  Refers to cancers that start in the oropharynx (posterior to the oral cavity)  For convenience, these modules will refer to oral cavity and oropharyngeal cancers as “oral cancer”

Oropharyngeal Cancers: Statistics for the United States  The American Cancer Society estimates 29,370 new cases of oral cavity and oropharyngeal cancer in 2005  About 7,320 will die from the disease during 2005

Cancer Survival*(%) by Site and Race, *5-year relative survival rates based on cancer patients diagnosed from 1992 to 1999 and followed through Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, All Sites Breast (female) Colon & rectum Leukemia Non-Hodgkin lymphoma Oral cavity Prostate Urinary bladder Uterine cervix Site White% Difference African American

The totals in this figure include unstaged cancers. Data source: Surveillance, Epidemiology, and End Results (SEER) 11 Registries Public-Use, August 1999 Submission ( ). The rates are per 100,000 and are age-adjusted to the 1970 U.S. standard population. Incidence rates for oral and pharyngeal cancers ( ) by stage at diagnosis &race/ethnicity

* The totals in this figure include the unstaged cancers. Data source: Surveillance, Epidemiology, and End Results (SEER) 9 Registries Public-Use, August 1999 Submission ( ). The rates are per 100,000 and are age-adjusted to the 1970 U.S. standard population. Incidence rates for oral and pharyngeal cancers ( ) by stage at diagnosis and gender

Data source: 1998 National Health Interview Survey, National Center for Health Statistics, Centers for Disease Control and Prevention. Percentage of adults aged 40 and older who reported having had an oral cancer examination in the past year

* Age adjusted to the year 2000 U.S. standard population. Data source: 1998 National Vital Statistics System, National Center for Health Statistics, Centers for Disease Control and Prevention. Oral and pharyngeal cancer deaths (per 100,000*) in 1998 by race/ethnicity, gender and education

State of Illinois Statistics

Average Annual Age-adjusted Rates and Distributions Oral Cavity and Oropharyngeal Cancer Incidence and Mortality by Subsite All Races, Both Sexes, Illinois vs. National, 2000 IncidenceMortality IllinoisSEER†IllinoisU.S.‡ SiteRateCount%RateCount%RateCount%RateCount% Lip Tongue , Salivary Gland Floor of Mouth Gum/Other Mouth , Nasopharynx Tonsil Oropharynx Hypopharynx Other Oral Cavity , Total10.51, , ,

Stage at Diagnosis of Oral Cavity and Oropharyngeal Cancer Incidence Average Annual Percentages for 5-year Time Periods All Races, Both Sexes, Illinois, Source: Illinois Department of Public Health, Illinois State Cancer Registry, January 2003

Incidence & Mortality, Buccal Cavity and Pharynx, Both Sexes, All RacesWhitesBlacksAsian/Other IllinoisCountRateCountRateCountRateCountRate Incidence18, , , Mortality5, , , State of Illinois Illinois Department of Public Health, Illinois State Cancer Registry, January 2003

State of Illinois Statistics Incidence Rate for Oral Cancer, Illinois US WomenMenWomenMen American Cancer Society, 2004

Illinois Statistics Mortality Rate for Oral Cancer, Illinois US WomenMenWomenMen American Cancer Society, 2004

Stage at Diagnosis of Oral Cavity and Oropharyngeal Cancer Incidence § Average Annual Percentages for 5-year Time Periods All Races, Both Sexes, Illinois, Figure 11 Oral Cavity and Oropharyngeal Cancer Incidences, (Site-Race-Ethnicity)  Includes only invasive cancers. Hispanics/non-Hispanics are not mutually exclusive from whites, blacks and  Asian/other races.Source: Illinois Department of Public Health, Illinois State Cancer Registry, January 2003

Oral Cavity and Oropharynx Average Annual Age-adjusted Cancer Rates by Gender and Race/Ethnicity in Illinois, Incidence§ and Mortality,

Percentage Cases Diagnosed at Early Stage Oral Cavity and Oropharyngeal Cancer Incidence§ Illinois Counties, Figure 14 Oral Cavity and Oropharyngeal Cancer Incidence in Illinois Counties ( )

Summary  Oropharyngeal cancers are prevalent throughout the U.S. and in the State of Illinois  Men face a greater risk than women, with African American men facing the greatest risk